CD40 and mesothelioma: Therefore, to address this issue we examined the role of macrophages in young (3 months) vs. elderly (20–24 months) mesothelioma-bearing female C57BL/6J mice during tumor growth and following treatment with intra-tumoral IL-2/anti-CD40 immunotherapy.